SPRC: חוב לטווח קצר של החברה SciSparc Ltd

SciSparc Ltd (SPRC) utilizes AI and robotics to accelerate the development of drugs targeting CNS pathologies, which is confirmed by the asset's market dynamics on GURU.Markets, where the indicator stands at 0.00. The automation of compound screening reduces the number of biologists required, thereby speeding up the discovery of formulas. Meanwhile, the company delegates initial testing to external centers while retaining exclusive intellectual property rights.

To isolate the fundamental stability of SciSparc Ltd (SPRC) from market noise, an analysis of current liabilities measuring debt with a maturity horizon of up to one year is critical. The short-term financial debt dynamics demonstrate a buffer of operational liquidity, which is particularly significant for the biotech sector during the development of autism therapies, where minimizing the debt load ensures a stable path toward generating long-term patent revenues.